国际妇产科学杂志 ›› 2026, Vol. 53 ›› Issue (1): 8-11.doi: 10.12280/gjfckx.20250893

• 妇科肿瘤研究: 综述 • 上一篇    下一篇

循环肿瘤DNA在卵巢癌早期诊断的研究进展

徐若兰(), 杨将, 王冉冉, 周金婷()   

  1. 430000 武汉科技大学医学部医学院(徐若兰);襄阳市中心医院妇产科(杨将,王冉冉,周金婷)
  • 收稿日期:2025-08-10 出版日期:2026-02-15 发布日期:2026-03-11
  • 通讯作者: 周金婷 E-mail:409484199@qq.com
  • 基金资助:
    湖北省中医药管理局中医药科研项目(ZY2023Q022)

Research Progress on Circulating Tumor DNA in the Early Diagnosis of Ovarian Cancer

XU Ruo-lan(), YANG Jiang, WANG Ran-ran, ZHOU Jin-ting()   

  1. School of Medicine, Wuhan University of Science and Technology, Wuhan 430000, China (XU Ruo-lan); Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Xiangyang 441000, Hubei Province, China (YANG Jiang, WANG Ran-ran, ZHOU Jin-ting)
  • Received:2025-08-10 Published:2026-02-15 Online:2026-03-11
  • Contact: ZHOU Jin-ting E-mail:409484199@qq.com

摘要:

卵巢癌是女性生殖系统致死率极高的恶性肿瘤之一,其早期症状不明显,易误诊漏诊,超过70%的患者在确诊时已属晚期,且生存率较低。目前,糖类抗原125、经阴道超声检查等常用筛查手段在卵巢癌早期诊断中的敏感度和特异度均有限。近年来,随基因测序技术的发展,分子诊断成为卵巢癌早期检测的重要手段,尤其是基于循环肿瘤DNA(circulating tumor DNA,ctDNA)的检测受到广泛关注。ctDNA是肿瘤细胞释放到血液中的DNA片段,携带肿瘤特征,能动态、实时地反映肿瘤状态。基于ctDNA的卵巢癌突变检测、甲基化模式识别,显著提高了检测敏感度。此外,ctDNA与机器学习方法的结合进一步提升了卵巢癌的早期检出率。未来,检测技术和大规模人群数据的研究以及多组学数据整合将极大地推动ctDNA在卵巢癌诊疗中的应用,提升患者的生存质量。

关键词: 循环肿瘤DNA, 卵巢肿瘤, 癌, 序列分析,DNA, 甲基化, 机器学习, 早期诊断

Abstract:

Ovarian cancer is one of the malignant tumors with extremely high mortality in the female reproductive system. Its early symptoms are not obvious, and it is prone to misdiagnosis and missed diagnosis. More than 70% of patients are already in the advanced stage at the time of diagnosis, and the survival rate is relatively low. Currently, the sensitivity and specificity of common screening methods such as carbohydrate antigen 125 testing and transvaginal ultrasound examination in the early diagnosis of ovarian cancer are limited. In recent years, with the development of gene sequencing technology, molecular diagnosis has become an important means for the early detection of ovarian cancer. In particular, the detection based on circulating tumor DNA (ctDNA) has received extensive attention. CtDNA is a DNA fragment released by tumor cells into the blood, carrying tumor characteristics and capable of dynamically and real-time reflecting the tumor's status. The mutation detection and methylation pattern recognition of ovarian cancer based on ctDNA have significantly improved the detection sensitivity. In addition, the combination of ctDNA and machine learning methods has further increased the early detection rate of ovarian cancer. In the future, with the research on detection technology and large-scale population data, as well as the integration of multi-omics data, the application of ctDNA in the diagnosis and treatment of ovarian cancer will be greatly promoted, and the quality of patients' lives will be improved.

Key words: Circulating tumor DNA, Ovarian neoplasms, Carcinoma, Sequence analysis, DNA, Methylation, Machine learning, Early diagnosis